Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. (MRTX) is a publicly traded company in the Unknown sector. Across all available filings, 45 corporate insiders have executed 634 transactions totaling $855.4M, demonstrating a bearish sentiment with -$493.8M in net insider flow. The most recent transaction on Jan 23, 2024 involved a transaction of 7,555 shares valued at $0.
MRTX Insider Activity Summary
Who Is Buying MRTX Stock?
No significant insider buying has been recorded for MRTX in the recent period.
Who Is Selling MRTX Stock?
No significant insider selling has been recorded for MRTX in the recent period.
Is Mirati Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MRTX is bearish with an Insider Alignment Score of 21/100 and a net flow of -$493.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
MRTX Frequently Asked Questions
Understanding MRTX Insider Activity
Insider trading at Mirati Therapeutics, Inc. (MRTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 45 insiders are actively trading MRTX stock, having executed 634 transactions in the past 90 days. The most active insider is Capital, Llc Boxer (Executive), who has made 29 transactions totaling $206.2M.
Related Tools
Track Mirati Therapeutics, Inc. Insider Activity
Get notified when executives and directors at MRTX file new Form 4 transactions